)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Hikma Pharmaceuticals (HIK) investor relations material
Hikma Pharmaceuticals Trading Update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Trading Update summary6 Nov, 2025
Business performance and outlook
All business segments are performing well and are on track to meet 2025 guidance, with strong growth expected in 2026 and 2027.
Group revenue CAGR for 2024–2027 is now expected at the lower end of the 6–8% range, and core EBIT CAGR is revised to 5–7%.
The target of $5 billion group revenue by 2030 is maintained, supported by injectables, MENA growth, and a robust Rx business.
2025 group revenue is expected to grow 4% to 6%, with core operating profit of $730–$750 million.
No share buyback is planned, with investment prioritized for business growth.
Injectable segment update
Medium-term injectable margins are now guided at around 30%, down from mid-30s, due to Bedford facility delays, increased R&D, and geographic expansion.
Injectables revenue growth for 2025 is forecast at 7% to 9%, with a core margin of 32% to 33%.
Bedford site operational delays push commercial production to 2028, impacting margin timing.
Growth in Europe and MENA is strong but comes with lower margins compared to the US.
The 30% margin is set as a confident floor, with potential for future upside as new capacity and products come online.
Rx and generics segment update
Rx margins are expected to approach 20% by 2026, driven by a strong base portfolio, pipeline expansion, and CMO growth.
Hikma Rx revenue projected to be broadly flat in 2025, with core margin around 16%.
Contract manufacturing and increased R&D investment are key contributors to Rx margin improvement.
The Rx business strategy is delivering, with new lines, increased capacity, and a focus on complex products.
Injectables margin: What's the 2026 outlook?
Rx margin: Key drivers for 20% by 2026?
R&D restructuring: What's the strategic impact?
What is the primary driver of Injectables margin shift?
What drives Rx margin to 20% beyond Jazz royalties?
How will R&D restructuring impact 2030 target?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Hikma Pharmaceuticals earnings date
H2 202525 Feb, 2026
Next Hikma Pharmaceuticals earnings date
H2 202525 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company specializing in the development, manufacturing, and distribution of branded, generic, and injectable medicines. The company serves a wide range of therapeutic areas, including cardiovascular, oncology, pain management, and respiratory diseases. Hikma provides high-quality, affordable medications to hospitals, pharmacies, and wholesalers in global markets. The company is headquartered in London, United Kingdom, and its shares are listed on the LSE (London Stock Exchange).
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage